P2P: Part-to-Part Motion Cues Guide a Strong Tracking Framework for LiDAR Point Clouds
International Journal of Computer Vision · 2025-08 · 133 (8) · 5326-5342
DOI: 10.1007/s11263-025-02430-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Computer Vision, online erschienen am 21.04.2025. Verfasst von Jiahao Nie und 5 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government, Institute of Information & communications Technology Planning & Evaluation grant funded by the Korea government, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korea government
- Institute of Information & communications Technology Planning & Evaluation grant funded by the Korea government
- National Natural Science Foundation of China
- Zhejiang Provincial Major Research and Development Project of China
- Central Guiding Local Science and Technology Development Fund Projects of China
Zitieren
APA
Nie, J., Xie, F., Zhou, S., Zhou, X., Chae, D., & He, Z. (2025). P2P: Part-to-Part Motion Cues Guide a Strong Tracking Framework for LiDAR Point Clouds. International Journal of Computer Vision, 133(8), 5326-5342. https://doi.org/10.1007/s11263-025-02430-6
Vancouver
Nie J, Xie F, Zhou S, Zhou X, Chae D, He Z. P2P: Part-to-Part Motion Cues Guide a Strong Tracking Framework for LiDAR Point Clouds. International Journal of Computer Vision. 2025;133(8):5326-5342. doi:10.1007/s11263-025-02430-6
BibTeX
@article{Nie2025,
author = {Nie, Jiahao and Xie, Fei and Zhou, Sifan and Zhou, Xueyi and Chae, Dong-Kyu and He, Zhiwei},
title = {P2P: Part-to-Part Motion Cues Guide a Strong Tracking Framework for LiDAR Point Clouds},
journal = {International Journal of Computer Vision},
year = {2025},
volume = {133},
number = {8},
pages = {5326--5342},
doi = {10.1007/s11263-025-02430-6}
}
EUVIMED